Insulet Corp. Insulet Corp.

Insulet Corp.

PODD

Peringkat dalam Saham #2095
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Harga Saham
$140.99
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$9.78B
Perubahan (1 hari)
1.60%
Perubahan (1 tahun)
-55.75%
Negara
US
Perdagangan Insulet Corp. (PODD)

Kategori

Healthcare
Riwayat dividen untuk Insulet Corp. (PODD)
Saham Insulet Corp. (simbol: PODD) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Insulet Corp. (PODD) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
173.00%
US
178.00%
IE
85.00%
US
0.00%
US
0.00%
DE